These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8225391

  • 1. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
    Chen H, Luo H, Daloze P, Xu D, Shan X, St-Louis G, Wu J.
    Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
    [Abstract] [Full Text] [Related]

  • 2. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P, Chen H, Luo H, Xu D, Shan X, Wu J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
    [No Abstract] [Full Text] [Related]

  • 4. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
    Chen H, Wu J, Xu D, Luo H, Daloze PM.
    Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
    [Abstract] [Full Text] [Related]

  • 5. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
    Ferraresso M, Tian L, Ghobrial R, Stepkowski SM, Kahan BD.
    J Immunol; 1994 Oct 01; 153(7):3307-18. PubMed ID: 8089500
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B, Wieder KJ, Hancock WW, Zheng XX, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1996 Jan 01; 156(1):395-404. PubMed ID: 8598490
    [Abstract] [Full Text] [Related]

  • 13. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
    Ferraresso M, Ghobrial R, Stepkowski SM, Kahan BD.
    Transplantation; 1993 Apr 01; 55(4):888-94. PubMed ID: 8475565
    [Abstract] [Full Text] [Related]

  • 14. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S, Ito T, Kamiike W, Uchikoshi F, Yamamoto S, Nakata S, Shirakura R, Miyata M, Matsuda H, Stepkowski SM.
    Transplant Proc; 1994 Aug 01; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract] [Full Text] [Related]

  • 15. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery.
    Tian L, Lu L, Yuan Z, Lamb JR, Tam PK.
    Transplantation; 2004 Jan 27; 77(2):183-9. PubMed ID: 14742978
    [Abstract] [Full Text] [Related]

  • 16. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J, Sayegh MH, Watschinger B, Hancock WW, Kupiec-Weglinski JW.
    Transplantation; 1994 Jul 15; 58(1):80-6. PubMed ID: 8036712
    [Abstract] [Full Text] [Related]

  • 17. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
    Chen H, Xu D, Qi S, Wu J, Luo H, Daloze P.
    Transplantation; 1995 Apr 27; 59(8):1084-9. PubMed ID: 7732551
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
    Poston RS, Billingham M, Hoyt EG, Pollard J, Shorthouse R, Morris RE, Robbins RC.
    Circulation; 1999 Jul 06; 100(1):67-74. PubMed ID: 10393683
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G, Hancock WW, Wasowska B, Binder J, Padberg W, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 06; 27(1):427-9. PubMed ID: 7879048
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
    Stepkowski SM, Chen HF, Wang ME, Daloze P, Kahan BD.
    Transplantation; 1992 Feb 06; 53(2):258-64. PubMed ID: 1738917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.